Nitroaspirin (NOASA; NCX4016; mNOASA) is a novel and potent nitric oxide (NO) donor with anticancer, antithrombotic and anti-platelet activities. It is a nitro-derivative of Aspirin that can inhibit cyclooxygenase/COX. Also acting as a dual inhibitor of arginase and iNOS with immunomodulatory activity, may be used for cancer immunotherapy.

纯度：≥98%

CAS：175033-36-0